Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.9.5017

MicroRNA-122 Promotes Proliferation, Invasion and Migration of Renal Cell Carcinoma Cells Through the PI3K/Akt Signaling Pathway  

Lian, Ji-Hu (Department of Urology, China-Japan Union Hospital of Jilin University)
Wang, Wei-Hua (Department of Urology, China-Japan Union Hospital of Jilin University)
Wang, Jia-Qiang (Department of Urology, Jilin Province People's Hospital)
Zhang, Yu-Hong (Department of Urology, Jilin Province People's Hospital)
Li, Yi (Department of Urology, Jilin Province People's Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.9, 2013 , pp. 5017-5021 More about this Journal
Abstract
Objective: MicroRNAs (miRNAs) are a small class of non-coding, single-stranded RNAs with a critical role in genesis and maintenance of renal cancer mainly through binding to 3'-untranslated regions (3'UTR) of target mRNAs, which causes a block of translation and/or mRNA degradation. The aim of the present study was to investigate the potential effects of miR-122 in human renal cell carcinomas. Methods: The expression level of miR-122 was quantified by qRT-PCR. MTT, colony formation, invasion and migration assays were used to explore the potential functions of miR-122 in human renal cell carcinoma cells. Results: Cellular growth, invasion and migration in two A498 and 786-O cells were significantly increased after miR-122 transfection. Further experiments demonstrated that overexpression of miR-122 resulted in the increase of phospho-Akt (Ser473) and phospho-mTOR (Ser2448), then activation of mTOR targets, p70S6K and 4E-BP1. Conclusions: The up-regulation of miR-122 may play an important role in the progress of renal cancer through activating PI3K/Akt signal pathway and could be a potential molecular target for anti-cancer therapeutics.
Keywords
miR-122; renal cell carcinoma; invasion; migration;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Esau C, Davis S, Murray SF, et al (2006). miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab, 3, 87-98.   DOI   ScienceOn
2 Bai S, Nasser MW, Wang B, et al (2009). MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem, 284, 32015-27.   DOI   ScienceOn
3 Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97.   DOI   ScienceOn
4 Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz W (2006). Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell, 125, 1111-24.   DOI   ScienceOn
5 Couzin J (2008). MicroRNA make big impression in disease after disease. Science, 319, 1782-4.   DOI   ScienceOn
6 Filipowicz W, Bhattacharyya SN, Sonenberg N (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet, 9, 102-14.   DOI
7 Heinzelmann J, Henning B, Sanjmyatav J, et al (2011). Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma. World J Urol, 29, 367-73.   DOI
8 Lu J, Getz G, Miska EA, Alvarez-Saavedra E, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8.   DOI   ScienceOn
9 Ma L, Liu J, Shen J, et al (2010). Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells. Cancer Biol Ther, 9, 554-61.   DOI
10 Manfe V, Biskup E, Rosbjerg A, et al (2012). miR-122 regulates p53/Akt signaling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma. PloS One, 7, e29541   DOI
11 Milowsky MI, Nanus DM (2003). Chemotherapeutic strategies for renal cell carcinoma. Urol Clin North Am, 30, 601-9.   DOI   ScienceOn
12 Tsai WC, Hsu SD, Hsu CS, et al (2012). MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest, 122, 2884-97.   DOI   ScienceOn
13 Novick AC (2007). Kidney cancer: past, present, and future. Urol Oncol, 25, 188-95.   DOI   ScienceOn
14 Osanto S, Qin Y, Buermans HP, et al (2012). Genome-wide microRNA expression analysis of clear renal cell carcinoma by next generation deep sequencing. PLoS One, 7, e38298.   DOI
15 Rouviere O, Bouvier R, Negrier S, Badet L, Lyonnet D (2006). Nonmetastatic renal-cell carcinoma: is it really possible to define rational guidelines for post-treatment follow-up? Nat Clin Pract Oncol, 3, 200-13.
16 Wang B, Wang H, Yang Z (2012). MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R. PLoS One, 7, e47053.   DOI
17 Xu J, Zhu X, Wu L, et al (2012). MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/beta-catenin pathway. Liver Int, 32, 752-60.   DOI   ScienceOn
18 Chen C, Ridzon DA, Broomer AJ, et al (2005). Real time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res, 33, e179.   DOI   ScienceOn
19 Zhou L, Chen J, Li Z, et al (2010). Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 assoxiate with clear cell renal cell carcinoma. PLoS One, 5, e15224.   DOI   ScienceOn